anthracene has been researched along with Psoriasis in 3 studies
*Psoriasis: A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gawlik, I; Huang, HS; Müller, K; Prinz, H; Ziereis, K | 1 |
| HINCKY, M; SIDI, E | 1 |
| MARSH, WC | 1 |
3 other study(ies) available for anthracene and Psoriasis
| Article | Year |
|---|---|
Simple analogues of anthralin: unusual specificity of structure and antiproliferative activity.
Topics: Administration, Topical; Animals; Anthralin; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arachidonate 5-Lipoxygenase; Cattle; Cell Division; Humans; Keratinocytes; Leukocytes, Mononuclear; Lipoxygenase Inhibitors; Oxidants; Psoriasis; Sensitivity and Specificity; Structure-Activity Relationship | 1997 |
[Comparative action of various reducing agents in the local treatment of psoriasis; clinical experimentation on anthrarobin].
Topics: Anthracenes; Humans; Psoriasis; Reducing Agents | 1956 |
Psoriasis; clinical evaluation of cainolin ointment in its treatment.
Topics: Anthracenes; Humans; Iodoquinol; Ointments; Psoriasis; Salicylic Acid | 1955 |